(lp0
S'Acura Pharmaceuticals Seeks To Raise $5 Million In Offering Seeking Alpha - Feb 7, 2017 Acura Pharmaceuticals has filed to raise $5 million in a follow-on stock and warrant offering. The company is commercializing tamper-resistant medication technologies, but appears to be running out of money and time.'
p1
aS'News Acura Pharmaceuticals Inc.ACUR Wall Street Journal - Feb 13, 2011 News Acura Pharmaceuticals Inc.ACUR. Significant News Only. 03/31/17; Press Release. Acura Pharmaceuticals Announces Fourth Quarter 2016 and Full Year 2016 Financial Results.'
p2
aS'Acura Pharmaceuticals Inc : Is An Exposure Worth The Risk? Insider Financial - Feb 9, 2017 Acura Pharmaceuticals, Inc. started out this week at circa $0.5 a share. By mid week, it had risen to more than $1.3, and currently trades for just shy of $1.'
p3
aS"Why Pfizer And Publix Will Ramp Up Acura Pharmaceuticals Seeking Alpha - Sep 24, 2013 One such company which has seen recent, dramatic spikes on positive news is Acura Pharmaceuticals . Just pull up a 12 month chart and you will see what I'm talking about."
p4
aS'Stock Update : Acura Pharmaceuticals, Inc. Provides Development ... Smarter Analyst - Dec 15, 2016 Acura Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration  has provided the Company with advice on the continued development of its product candidate LTX-04  which utilizes the&nbsp;...'
p5
aS"Acura Pharmaceuticals'  CEO Bob Jones on Q3 2016 Results - Earnings Call ... Seeking Alpha - Nov 15, 2016 ... to maximize this potential, future product sales, financial results and the company's strategy for near-term financing and long-term growth."
p6
aS'ACURA PHARMACEUTICALS, INC.  Files An 8-K Entry into a Material ... Market Exclusive - Mar 17, 2017 Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse.'
p7
aS'Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize ... Marketwired  - Jan 8, 2015 PALATINE, IL-- - Acura Pharmaceuticals, Inc.  today announced that the Company has entered into a Collaboration and License Agreement  with Egalet US, Inc. and Egalet Ltd.Egalet Acquires/Licenses Two Innovative Approved Pain Products - GlobeNewswire '
p8
aS'Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial ... Marketwired  - Feb 29, 2016 PALATINE, IL-- - Acura Pharmaceuticals, Inc. , a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the year and three months ended December 31,&nbsp;...'
p9
aS'Acura Pharmaceuticals, Inc.  Files An 8-K Announces Third Quarter ... Market Exclusive - Nov 14, 2016 Acura Pharmaceuticals, Inc. , a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine months ended September 30, 2016.'
p10
a.